Nociception: How Pain Signals Travel

Why nociception matters

• It is the alarm that keeps you alive. People with congenital insensitivity to pain — most caused by loss-of-function mutations in SCN9A, the gene for the sodium channel Nav1.7 — have intact peripheral receptors yet never feel pain. They routinely bite off the tip of their tongue, burn themselves without noticing, sustain painless fractures, and frequently die young. Nociception is a protective necessity, not an optional discomfort.
• Pain is the number-one reason people see a doctor. Chronic pain affects roughly 20% of adults worldwide and is the leading cause of disability and lost workdays. Understanding the nociceptive pathway is the foundation of every analgesic strategy, from ibuprofen to spinal cord stimulators.
• The opioid crisis is a nociception story. Opioids act on mu-opioid receptors in the dorsal horn and brainstem to close Melzack and Wall's gate from above. Their power and their danger both stem from acting on the same modulatory circuitry that normally dampens pain, which is why decoding non-opioid targets in the pathway is one of the most active areas in pharmacology.
• The 2021 Nobel Prize put molecules to the sensation. David Julius identified TRPV1 as the receptor for heat and capsaicin; Ardem Patapoutian identified the PIEZO1 and PIEZO2 mechanically gated channels for touch and pressure. For the first time, we could name the exact proteins that turn a noxious stimulus into an electrical signal.
• Chili heat and menthol cool are the same trick in reverse. Capsaicin opens the heat channel TRPV1 without any real heat; menthol opens the cold channel TRPM8 without any real cold. Both hijack thermal nociception directly, proving that what we feel is the channel opening, not the temperature itself.
• Sensitization explains why injuries keep hurting. After a sunburn, a warm shower feels scalding and a soft shirt feels like sandpaper. That is peripheral and central sensitization lowering thresholds — a normally adaptive response that, when it fails to switch off, becomes chronic and neuropathic pain.
• It is a target-rich landscape. Nav1.7 blockers, NGF antibodies (tanezumab), CGRP antibodies for migraine, and TRPV1 agonists such as the high-dose capsaicin patch Qutenza all intervene at specific nodes of the nociceptive pathway — each one traceable to a discovery about how the signal is generated and carried.

Common misconceptions

• "Nociception and pain are the same thing." They are not. Nociception is the mechanical detection and transmission of a noxious stimulus; pain is the conscious experience the brain builds from it. You can have nociception without pain (under anesthesia, spinal reflexes still fire) and pain without nociception (phantom limb pain, central pain syndromes). The brain is the final author of pain, not the skin.
• "There are dedicated pain nerves that only do pain." Nociceptors are free nerve endings — bare, unspecialized terminals — not encapsulated corpuscles like the touch-sensing Meissner or Pacinian bodies. What makes them nociceptive is the molecular receptors they express (TRPV1, TRPA1, ASICs, PIEZO2, Nav1.7/1.8) and their high activation thresholds, not a special anatomical structure.
• "Faster fibers mean the pain is worse." Speed encodes timing, not severity. Fast A-delta fibers deliver the sharp, immediate first pain that triggers withdrawal; slow C fibers deliver the delayed, burning second pain. The C-fiber ache is often the more distressing of the two despite being carried by the slowest axons in the body.
• "Capsaicin physically burns the tissue." Capsaicin causes no thermal or chemical injury at culinary doses. It simply binds and opens TRPV1, so the nociceptor sends the identical signal it would send during a real burn. The "heat" of a chili is a pure signaling illusion, which is exactly why prolonged exposure can desensitize the nerve and relieve pain.
• "Rubbing an injury only distracts you." Gate control theory shows it is genuinely physiological. Large A-beta touch fibers drive inhibitory interneurons in the dorsal horn that clamp down on the pain-relaying projection neurons — you are literally closing a neural gate, the same principle a TENS unit exploits.
• "Pain always crosses to the brain on the same side." The spinothalamic tract crosses the midline within one or two segments of entering the cord, so pain and temperature ascend on the opposite side. This is why a one-sided cord lesion (Brown-Sequard syndrome) abolishes pain on the contralateral body below the lesion while touch and proprioception fail on the same side.

How nociception works, step by step

1. Transduction. A noxious stimulus reaches a free nerve ending in the skin, muscle, joint, or viscera. Specialized receptor proteins convert the physical energy into an electrical change. Heat above about 43 °C, low pH, and capsaicin open TRPV1; noxious cold and irritants (mustard oil, tear gas, environmental toxins) open TRPA1; intense mechanical force opens the piezo channel PIEZO2 and acid-sensing channels (ASICs) respond to the protons of injured tissue. Each opening lets sodium and calcium in, producing a graded depolarizing generator potential at the terminal.

2. Initiation of the impulse. If the generator potential is large enough, voltage-gated sodium channels — chiefly Nav1.7 (the amplifier and threshold-setter) and Nav1.8 (which carries the upstroke and works even in the cold) — fire an all-or-none action potential. Nav1.7 is so pivotal that losing it abolishes pain entirely and gaining function in it causes the burning agony of inherited erythromelalgia.

3. Conduction along two fiber types. The impulse travels toward the spinal cord along two distinct afferents whose speeds create the double sensation of pain. A-delta fibers are thinly myelinated, so saltatory conduction lets them run at 5–30 m/s, delivering sharp, well-localized first pain. C fibers are unmyelinated and conduct at only 0.5–2 m/s, delivering the dull, burning, poorly localized second pain; they make up roughly 70% of all nociceptive afferents. The cell bodies of both sit in the dorsal root ganglion, just outside the cord.

4. The dorsal horn synapse and the gate. The fibers enter the cord and synapse in laminae of the dorsal horn (A-delta mainly in laminae I and V, C fibers in laminae I and II, the substantia gelatinosa). They release glutamate and, from C fibers, the neuropeptides substance P and CGRP onto second-order projection neurons. Here the gate control circuit of Melzack and Wall operates: incoming non-painful A-beta touch input excites inhibitory interneurons that suppress the projection neurons, damping the pain signal, while descending fibers from the brainstem periaqueductal gray release endorphins, serotonin, and noradrenaline to close the gate from above.

5. Ascent up the spinothalamic tract. The second-order projection neuron sends its axon across the midline within one or two segments and ascends the contralateral spinothalamic tract (part of the anterolateral system) to the thalamus. The lateral, sensory-discriminative stream reaches the ventral posterolateral nucleus and then the somatosensory cortex to tell you where and how intense; the medial, affective stream reaches the insula and anterior cingulate cortex to supply the unpleasantness. Only now, in cortex, does nociception become the felt experience of pain.

6. Sensitization amplifies the signal. If tissue is inflamed, released prostaglandins, bradykinin, histamine, protons, and nerve growth factor form an inflammatory soup that phosphorylates TRPV1 and Nav channels, lowering the nociceptor's threshold — peripheral sensitization. Repeated C-fiber firing drives glutamate onto NMDA receptors in the dorsal horn, relieving their magnesium block and making projection neurons hyperexcitable with expanded receptive fields — central sensitization and the phenomenon of "wind-up." The results are hyperalgesia (painful things hurt more) and allodynia (harmless touch becomes painful).

A-delta fibers vs C fibers

Property	A-delta fibers	C fibers
Myelination	Thinly myelinated	Unmyelinated
Diameter	1–5 µm	0.2–1.5 µm
Conduction speed	5–30 m/s	0.5–2 m/s
Pain quality	Sharp, pricking (first pain)	Dull, burning, aching (second pain)
Localization	Well localized	Poorly localized, diffuse
Onset after injury	Immediate (<0.1 s)	Delayed (~1 s later)
Share of nociceptors	~30%	~70%
Main dorsal horn target	Laminae I and V	Laminae I and II (substantia gelatinosa)
Reflex role	Drives fast withdrawal reflex	Sustains protective guarding

Nociception vs fine touch — two ascending systems

Feature	Nociception / temperature	Fine touch / proprioception
Receptor type	Free nerve endings (nociceptors)	Encapsulated corpuscles (Meissner, Pacinian, Merkel, Ruffini)
Fiber class	A-delta and C	Large A-beta
Ascending pathway	Spinothalamic tract (anterolateral system)	Dorsal column–medial lemniscus
Where it crosses midline	In the spinal cord, near entry	In the medulla (at the gracile/cuneate nuclei)
First synapse	Dorsal horn of spinal cord	Dorsal column nuclei of the medulla
Molecular sensors	TRPV1, TRPA1, ASICs, PIEZO2, Nav1.7/1.8	PIEZO2, mechanosensitive channels
Effect of one-sided cord lesion	Loss on the opposite side below lesion	Loss on the same side below lesion

Famous experiments and history

• Melzack and Wall, gate control theory (1965). Ronald Melzack and Patrick Wall published "Pain Mechanisms: A New Theory" in Science (150: 971–979), proposing that a spinal gate in the substantia gelatinosa balances large-fiber touch input against small-fiber pain input. It overturned the centuries-old "specificity" view of pain as a simple wire from skin to brain and launched the modern field of pain modulation, directly inspiring TENS units and spinal cord stimulators.
• David Julius clones TRPV1 (1997). Michael Caterina, Julius, and colleagues screened a rat dorsal-root-ganglion cDNA library in cultured cells for capsaicin responsiveness and isolated the vanilloid receptor VR1, now TRPV1, reported in Nature (389: 816–824). They then showed the same channel is opened by noxious heat above ~43 °C, molecularly unifying the sensations of chili heat and a burn.
• Ardem Patapoutian and the PIEZO channels (2010). Patapoutian's lab poked cells with a micropipette while silencing candidate genes one at a time until mechanically evoked currents vanished, identifying PIEZO1 and PIEZO2 — the long-sought mechanically gated ion channels behind touch, pressure, and mechanical nociception. PIEZO2 turned out to be essential for gentle touch and for some forms of mechanical pain.
• The 2021 Nobel Prize. Julius and Patapoutian shared the Nobel Prize in Physiology or Medicine "for their discoveries of receptors for temperature and touch," completing the molecular account of how the body converts heat, cold, and force into the electrical language of nociception.
• Nav1.7 and the pain-free family (2006). Cox and colleagues studied a Pakistani family, including a street performer who walked on hot coals and stabbed himself without pain, and traced their congenital insensitivity to pain to nonsense mutations in SCN9A/Nav1.7 (Nature 444: 894–898). The mirror-image gain-of-function mutations cause inherited erythromelalgia, sometimes called "man on fire" syndrome — making Nav1.7 one of the most sought-after analgesic targets.